The Fund aims to provide capital growth with some income.
Name | % Net Assets |
---|---|
GlaxoSmithKline PLC | 1.3% |
Royal Dutch Shell PLC | 1.2% |
BT Group PLC | 1.2% |
BG Group PLC | 1.1% |
BP PLC | 1.1% |
Rolls-Royce Holdings PLC | 0.8% |
Rio Tinto PLC | 0.8% |
British American Tobacco PLC | 0.8% |
Apple Inc. | 0.8% |
Legal & General Group PLC | 0.8% |
Key | % Net Assets |
---|---|
GlaxoSmithKline PLC | 1.3% |
Royal Dutch Shell PLC | 1.2% |
BT Group PLC | 1.2% |
BG Group PLC | 1.1% |
Other | 95.2% |
Date | 09-Apr-2021 |
---|---|
Bid | 208.50p |
Offer | 208.50p |
Currency | GBP |
Change | 1.00p |
% | 0.48% |
YTD change | 208.50p |
YTD % | n/a |
Fund Inception | 26/08/1997 |
---|---|
Fund Manager | Sarah Arkle / Alex Lyle |
TER | 1.68 (30-Mar-2012) |
Minimum Investment | |
---|---|
Initial | £2000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 3.75% |
Annual Mang't | 0.25% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.06 |
You are here: research